VUMC News and Communications

Vanderbilt Offers New Treatment for Age Related Macular Degeneration

Vanderbilt University Medical Center recently began offering a new treatment for wet age-related macular degeneration (AMD) that may improve, and in some cases restore, patients’ vision.

Psychiatric expert available to discuss Israel/Hezbollah conflict

Paul Ragan, M.D., associate professor of Psychiatry, Vanderbilt University School of Medicine, is available for interviews on the Israel/Hezbollah Conflict. He can address a wide range of topics in dealing with psychiatry issues in the military including acute stress disorders that are often rampant throughout a community when hundreds of thousands of people are displaced.

Vanderbilt studying new drug to treat severe ulcerative colitis Recruiting patients for clinical trial

People who suffer from severe ulcerative colitis may find relief from a new drug that is being tested at Vanderbilt University Medical Center.

Vanderbilt participating in West Nile vaccine trial

Vanderbilt University Medical Center researchers, in collaboration with investigators at Johns Hopkins University, are beginning a Phase I trial to test a new vaccine against the West Nile virus.

Health care workers with positive TB skin test should receive treatment

As the number of foreign-born health care workers in the United States has risen, so has the potential for transmitting tuberculosis in health-care settings.

Vanderbilt Children’s Hospital Research on the Flu in Children Resulted in New Vaccination Recommendations

The study that led the Centers for Disease Control and Prevention (CDC) to change its recommendations for giving flu shots to children is published in the July 6 edition of the New England Journal of Medicine.

1 419 420 421 422 423 436